Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Beigene Ltd.
Sponsor

Beigene Ltd.

Solaris Avenue 94, KY1-1108

About the sponsor

Beigene Ltd. supports clinical research in advanced and metastatic solid tumors, with an emphasis on immuno-oncology combinations and novel pathway-targeted agents.

  • Anti-PD-1–based combination therapy
  • TIGIT and other immune checkpoint targets
  • Antitumor activity in selected solid tumor types

The sponsor’s research in this area includes treatment approaches for difficult-to-treat solid malignancies across multiple tumor settings.

About Specializations

Beigene Ltd. runs clinical trials in conditions such as Non-small cell lung cancer stage III, Non-small cell lung cancer stage IV, Non-small cell lung cancer stage IIIA, Non-small cell lung cancer recurrent, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Non-small cell lung cancer stage III+5

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ociperlimab
  • Sponsor:Beigene Ltd.

Follicular lymphoma

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Beigene Ltd.

Squamous cell carcinoma of head and neck+2

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Lbl-007
  • Sponsor:Beigene Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.